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Abstract Although intracranial pressure (ICP) is essen-
tial to guide management of patients suffering from acute
brain diseases, this signal is often neglected outside the
neurocritical care environment. This is mainly attributed to
the intrinsic risks of the available invasive techniques,
which have prevented ICP monitoring in many conditions
affecting the intracranial homeostasis, from mild traumatic
brain injury to liver encephalopathy. In such scenario,
methods for non-invasive monitoring of ICP (nICP) could
improve clinical management of these conditions. A review
of the literature was performed on PUBMED using the
search keywords ‘Transcranial Doppler non-invasive
intracranial pressure.’ Transcranial Doppler (TCD) is a
technique primarily aimed at assessing the cerebrovascular
dynamics through the cerebral blood flow velocity (FV). Its
applicability for nICP assessment emerged from observa-
tion that some TCD-derived parameters change during
increase of ICP, such as the shape of FV pulse waveform or
pulsatility index. Methods were grouped as: based on TCD
pulsatility index; aimed at non-invasive estimation of
cerebral perfusion pressure and model-based methods.
Published studies present with different accuracies, with
prediction abilities (AUCs) for detection of
ICP C20 mmHg ranging from 0.62 to 0.92. This discrep-
ancy could result from inconsistent assessment measures
and application in different conditions, from traumatic
brain injury to hydrocephalus and stroke. Most of the
reports stress a potential advantage of TCD as it provides
the possibility to monitor changes of ICP in time. Overall
accuracy for TCD-based methods ranges around
±12 mmHg, with a great potential of tracing dynamical
changes of ICP in time, particularly those of vasogenic
nature.
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Introduction
Intracranial pressure (ICP) is an important monitoring
modality in the clinical management of several neurolog-
ical diseases carrying intrinsic risk of potentially lethal
intracranial hypertension (ICH). ICP essentially consists of
four components, driven by different physiological mech-
anisms [1]: inflow and volume of arterial blood, venous
blood outflow, cerebrospinal fluid (CSF) circulation, and
brain volume. These components are responsible for dif-
ferent patterns of ICH.
Although ICP can guide patient management in neuro-
critical care, it is not commonly monitored in many clinical
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conditions outside this environment. The invasive character
of the standard methods for ICP monitoring (epidural,
subdural, intraparenchymal, and intraventricular monitors)
and their associated risks to the patient (infections, brain
tissue lesions, and hemorrhage) contribute to this scenario.
They have prevented ICP monitoring in a broad range of
diseases like in patients with risk of coagulopathy, as well
as in other conditions in which invasive monitoring is not
considered or outweighed by the risks of the procedure.
Another downside is related to costs and availability:
invasive monitoring is an expensive technique, requires
trained personnel and neurosurgical settings. Average cost
of intraparenchymal microtransducer is US $600, addi-
tionally to US $6000–10,000 for the display monitor [2].
Provided that knowledge of ICP can be crucial for the
successful management of patients in many sub-critical
conditions, non-invasive estimation of ICP (nICP) may be
helpful when indications for invasive ICP monitoring are
not met and when it is not immediately available or even
contraindicated.
Transcranial Doppler Ultrasonography (TCD) was first
described by Aaslid et al. [3]. Apart from many clinical
applications, TCD waveform analysis has been investi-
gated as a technique for nICP estimation, and this could
represent one of its most useful applications outside the
critical care environment. It is conceivable if one considers
that increased ICP could affect the waveform of blood flow
velocity in major cerebral vessels which have compliant
walls. Such vessels are subjected to an external pressure
(ICP) and an internal pressure (arterial blood pressure—
ABP). Active tension of the arterial walls and the arterial
wall compliance are another (and unknown) parameters,
which undoubtedly fall into the equation. On top of this,
not only all changes in FV waveform, like low diastolic
cerebral blood flow velocity (FVd), peaked waveform, and
higher pulsatility index (PI) values can be observed with
TCD during elevated ICP, but also in arterial hypotension
and hypocapnia [4, 5].
TCD-based nICP methods are mainly based on
approximate semi-quantitative relationships between cere-
brovascular dynamics and ICP. They can be divided into
three categories: (I) methods based on the TCD-derived
pulsatility index; (II) methods based on the calculation of
non-invasive cerebral perfusion pressure (nCPP); and (III)
methods based on mathematical models.
Although derived from the same principle, there is a
considerable variability in the reported accuracy of these
methods inter- and intra-categories.
Considering the wide range of TCD applications as a
technique for nICP monitoring, the purpose of this review
is to generally present these methods and their documented
clinical or experimental applications with measures of
accuracy.
Methods
A review of the literature was performed on PUBMED
database using the search keywords ‘Transcranial Doppler
non-invasive intracranial pressure.’ Works from 1985 to
2015 were found, in a total of 98 studies. The inclusion
criteria were the use of Transcranial Doppler as tool for
non-invasive ICP with clinical or experimental applications
of such methods. Excluded papers consisted of works using
TCD, but with no application for non-invasive ICP esti-
mation, or absence of clinical or experimental applications
in papers describing methods using TCD for non-invasive
ICP estimation. The selected articles were then subdivided
into the three categories aforementioned. Only full-length
available articles in the English language were considered
(see flow diagram in Fig. 1). The total number of articles
considered was 37, with occasional repetitions within each
Fig. 1 Flow diagram representative of the methodological approach applied for the selection of articles
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nICP category, i.e., certain articles presented assessments
in more than one category.
Results for each nICP category are presented in
Tables 1, 2, and 3. They include main findings and mea-
sures of accuracy of the studies considered. Sections in
Results present major attributes of the nICP categories.
Results
Methods Based on the Correlation Between ICP
and PI (nICP_PI)
Pulsatility index describes quantitative and qualitative
changes in the morphology of the TCD waveform resulting
from cerebral perfusion pressure changes. It represents a
relationship between the difference of systolic flow
velocity (FVs) and FVd divided by mean flow velocity
(FVm). All possible methods based on TCD-derived pul-
satility index are based on observation that ICP and PI are
positively correlated during increases of ICP. However,
increase in PI is not specific for increase in ICP. In cer-
tain situations, such as a drop in CPP, PI presents an
increasing trend, which can be related to increases in ICP
or decreases in ABP (Fig. 2). The same behavior occurs
during decrease in PaCO2 (partial pressure of carbon
dioxide) or increase in pulsatility of ABP waveform.
Mathematically, PI can be expressed as inversely propor-
tional to mean CPP, directly proportional to pulse
amplitude of arterial blood pressure and non-linearly pro-
portional to the compliance of the arterial bed (Ca),
cerebrovascular resistance (CVR), and heart rate (HR) [6].
Table 1 presents the papers which studied the relation-
ship between PI and ICP. Accuracy of nICP estimation
varies from ±5 to ±43.8 mmHg. The most favorable
results are from Bellner et al. [7], in which the authors
found a 95 % confidence interval for prediction of
±4.2 mmHg and strong correlation coefficient with ICP,
R = 0.94 (p < 0.05). However, such results were never
replicated by other authors.
Methods Based on Estimation of CPP
The second approach for nICP monitoring was primarily
intended for estimating the nCPP. However, non-invasive
ICP can be calculated based on the assumption that
nICP = ABP - nCPP. Four methods are described in the
literature (Table 2).
nICP_Aaslid
Aaslid et al. [8] have determined CPP based on the
amplitudes of the fundamental frequency components of
FV (F) and of the arterial blood pressure (A):
nCPP ¼ FVm  A=F:
nICP_FVd
Some studies have demonstrated that specific patterns of
TCD waveform, such as a decrease in diastolic flow
velocity, reflect impaired cerebral perfusion caused by a
decrease in CPP [9, 10] (Fig. 3). Based on waveform
analysis of FV [10], the proposed equation was
nCPP ¼ ABPm  FVd
FVm
þ 14 mmHg:
14 mmHg is a calibration (zeroing) parameter established
for traumatic brain injury patients.
nCPP_Edouard
This method is based on the combination of the phasic
values of both FV and ABP. The non-invasive CPP (nCPP)
was calculated using the following formula [11]:
nCPP ¼ FVm½FVm  FVd
 
 ðABPm  ABPdÞ
where ABPm and ABPd are the mean and diastolic ABP,
respectively.
nICP_CrCP
Critical closing pressure (CrCP) represents a threshold of
ABP, below which the blood pressure in the brain
microvasculature is inadequate to prevent the collapse and
cessation of blood flow [12]. CrCP equals the sum of ICP
and vascular wall tension (WT) [12, 13]:
CrCP = ICP + WT. Given the association of this param-
eter with the vasomotor tone of small blood vessels (i.e.,
wall tension), CrCP may be able to provide information
regarding the state of cerebral haemodynamics in several
neurological conditions [12, 14–17] and then could reflect
changes in CPP (Fig. 4). The equation for nCPP estimation
based on CrCP is
nCPP ¼ ABP 0:734 0:266ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðCVRCaHR 2pÞ2 þ 1
q
2
64
3
75 7:026
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at
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d
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it
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it
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at
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at
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b
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p
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.6
2 (I
C
P
C
1
5
m
m
H
g
)
0
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at
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(p
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at
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b
et
w
ee
n
P
I
an
d
IC
P
in
su
ch
si
tu
at
io
n
s
w
as
R
=
0
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at
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b
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at
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b
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b
et
w
ee
n
ra
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P
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h
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P
m
o
n
it
o
ri
n
g
C
as
e-
re
p
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at
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b
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T
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P
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P
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b
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at
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p
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at
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p
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P
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b
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d
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p
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b
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v
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p
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b
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b
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b
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ra
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at
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at
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b
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b
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b
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ra
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at
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b
et
w
ee
n
lo
w
(B
4
0
m
m
H
g
)
an
d
n
o
rm
al
(C
8
0
m
m
H
g
)
C
P
P
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ra
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v
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p
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b
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CVR ¼ CPP
FV
Ca ¼ CaBV Amp
ABP Amp
:
Constant coefficients (0.734, 0.266, 7.026) were derived
from analysis of database of 232 TBI retrospective cases
[18]. CaBV Amp represents the fundamental amplitude of
the cerebral arterial blood volume. ABP Amp represents
the fundamental amplitude of arterial blood pressure.
The accuracy for these methods was mainly reported for
nCPP estimations and varied from ±12 to 48.9 mmHg.
Variability for nICP in this case ranged from ±9.19 to
±59.60 mmHg. Out of the four methods, the best accuracy
for prediction ICP was reported by Cardim et al. [19]
elsewhere, using the nICP_CrCP, in which ICP could be
predicted within a confidence interval of ±9.19 mmHg.
Model-based nICP Methods
Black-Box Model for Estimation of ICP (nICP_BB)
In this model, the intracranial compartment was considered
a black-box (BB) system, with ICP being a system
response to the incoming signal ABP [20]. The system
response was described in terms of a transfer function
between ABP and ICP [21, 22]. The transfer function was
controlled by TCD and ABP derived parameters, the so-
called TCD characteristics, which include ICP-related
parameters and an ABP to TCD transfer function. The rules
of this TCD-based linear control had been formerly
determined using a multiple regression model between
TCD characteristics and ABP-ICP transfer function on
datasets of reference patients. The output data provide
continuous full waveform of nICP (in mmHg) (Fig. 5).
Application of this model is summarized in Table 3.
Cerebrovascular Dynamics Model for Estimation of ICP
(nICP_Heldt [23, 24])
This model-based nICP method focuses on the major
intracranial compartments and their associated variables:
brain tissue, cerebral vasculature, and cerebrospinal fluid
(CSF). It continuously estimates and tracks ICP using mea-
surements of peripheral ABP and FV in the middle cerebral
artery (MCA). This physiological model of cerebrovascular
dynamics is represented by a circuit analog and provides
mathematical limits that relate the measured waveforms to
ICP. Patient-specific ICP estimations are produced by an
algorithm, with no calibration or training in specific popula-
tions needed. The dynamical model of CSF and cerebral blood
circulation has been first published by Ursino and Lodi [25].
Accuracy of this method is summarized in Table 3.T
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Non-linear Regressions
Modified Black-Box Model The previously described
black-box model for ICP estimation [20] adopts a linear
relationship among ABP, ICP, and FV. Xu et al. [26]
assuming that the relationships among these three signals
are more complex than linear models, and consequently not
adequate to depict the relationship between f and w coeffi-
cients (relationship between ABP and ICP and that
between ABP and FV, respectively), investigated the
adoption of several nonlinear regression approaches. Con-
sidering that nonlinear regressions such as support vector
machines (SVMs) [27], kernel spectral regression (KSR)
[28] have been proved to be more powerful for the pre-
diction problem than the linear ones [29, 30], the authors
proposed to use these approaches to model the relationship
between coefficients f and w.
The ICP estimation showed that the mean ICP error by
the nonlinear approaches can be reduced compared to the
original approach (Table 3). Statistical tests also demon-
strated that the ICP estimation error by the proposed
nonlinear kernel approaches is statistically smaller than
that obtained with nICP_BB.
Data Mining Hu et al. [31] initially proposed an inno-
vative data mining framework of nICP assessment. The
proposed framework explores the rules of deriving ICP
from ABP and FV that are captured implicitly by a signal
database without using a mathematical model. The main
strategy of the this framework is to provide a mapping
function to quantify the uncertainty of an ICP estimate
associated with each database entry, and to use this infor-
mation to determine the best entry to build an ICP
simulation model for an optimal ICP estimation. In com-
parison to Schmidt’s method (nICP_BB), for example, this
model presented a smaller median normalized prediction
error (bias), and a greater median correlation coefficient
between estimated and measured normalized ICP
(Table 3).
In another work of the same group, Kim et al. [32]
aimed at adopting a new (linear and nonlinear) mapping
functions into the previous data mining framework for
nICP estimation to demonstrate that the performance of
nICP assessment could be improved by utilizing
proper mapping functions. Results are summarized in
Table 3.
Semisupervised Learning As previously seen, FV wave-
form analysis has been frequently applied for non-invasive
ICP assessment. Kim et al. [33] introduced a non-invasive
detection of intracranial hypertension method based on the
TCD measurement of FV alone to demonstrate itsT
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performance both in the supervised and semisupervised
learning settings (Table 3).
Out of these five model-based methods, the best accu-
racy was reported by Kashif and Heldt et al. [24], in which
authors present a strong correlation between nICP and ICP
of R = 0.90, sensitivity of 83 %, specificity of 70 %, with
an AUC of 0.83 for detecting ICP C 20 mmHg. In addi-
tion, a 95 % CI for prediction of ICP of ±14.9 mmHg
(SDE of ±7.6 mmHg) was found for this method.
Although other reviewed methods presented smaller 95 %
CI, considering all measures of accuracy together,
nICP_Heldt was the one showing the best performance.
Discussion
Intracranial pressure and its management have been con-
sidered of fundamental importance in the treatment of
neurocritical patients. ICP monitoring has been available
since 1951, but it is important to realize that the monitor
itself contributes little to outcome without proper inter-
pretation and secondary analysis of the observed signal
[34]. Instead, a positive outcome depends on how the data
from the monitor are used and whether an effective treat-
ments exists [34]. In a recent study, Chesnut et al.,
demonstrated that there was no difference in primary
Fig. 2 PI behavior during drop in CPP observed in a traumatic brain-
injured patient (source: Brain Physics Laboratory TBI Database,
University of Cambridge). Dashed lines represent periods when PI
increased due to increase in ICP, independently of changes in ABP.
CPP cereberal perfusion pressure, PI pulsatility index, ICP intracra-
nial pressure, ABP arterial blood pressure, TBI traumatic brain injury
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outcome in TBI patients who received ICP monitoring
[35]. However, while this trial has internal validity, it has
not been externally validated and did not test whether
treatment of ICP per se makes a difference, but rather
compared two management protocols (patients with or
without ICP monitoring) [34]. Moreover, ICP should not be
considered solely as a ‘‘number,’’ as waveform analysis of
this parameter is also important [36]. For instance, ICP
waveform analysis can provide information on the state of
cerebrovascular reactivity (PRx index), compensatory
reserve (RAP index) and can be used to estimate individ-
ualized optimal cerebral perfusion pressure levels [37, 38].
Despite eventual complications that might raise from
invasive monitoring, direct methods still remain as the gold
standards [2]. When direct ICP monitoring is contraindicated,
a reliable non-invasive method would be helpful, at least in
the early stages of treatment, when it could act as a screening
tool. Such scenario would be beneficial to a wide range of
neurological conditions in which ICP monitoring is not
usually applied or is a neglected parameter, such as cerebral
malaria [39, 40], status epilepticus, mild or moderate TBI,
brain tumors. For an example, TCD has been demonstrated to
accurately screen patients with mild or moderate TBI at risk
of secondary neurological deterioration [41].
The advent of Transcranial Doppler Ultrasonography
allowed the development of several methods dedicated to
assess the cerebrovascular circulation and dynamics, par-
ticularly non-invasive assessment of ICP and CPP.
Moreover, subject to good fixing of ultrasound probes, it
allows monitoring of these parameters as they may change
in time. TCD comprises most of the features a nICP
method should contemplate: relatively low cost, risk-free,
easily available, portable, high temporal resolution,
repeatable and suitable for emergency and ambulatory
settings. Nevertheless, as most of the non-invasive tech-
niques, TCD also presents some intrinsic disadvantages
which can negatively influence its accuracy. They are
mainly represented by signal transmission attenuation
through the cranial bones, linearity and stability of the
signal in time. Furthermore, TCD measurements may be
especially difficult in a certain percentage of the population
(up to 8 %) which does not present an adequate acoustic
window for artery insonation [42]. On the other hand,
accuracy may not be the primary performance measure in
every clinical situation, and such downsides may be com-
pensated for by the ability of the method to track changes
and trends of ICP over time, rather than its absolute value.
In addition, a possible disadvantage about TCD is
related to its principle of working. It is known that this
technique is limited to detecting changes in the arterial bed
of vasogenic origin [43] (i.e., changes of arterial blood
volume). Considering that ICP consists of several compo-
nents (i.e., inflow and volume of arterial blood, venous
blood outflow, CSF circulation and brain parenchyma
volume), it is expected that a TCD-based method would
present lower accuracy if changes in ICP were caused, for
example, by derangements in the CSF circulation or by
increase in parenchyma volume, rather than if they were
purely of vasogenic origin. This is mainly because changes
in the CSF and brain parenchyma compartments would not
be promptly transmitted to the arterial bed as of those of
vasogenic origin. Such characteristic can be exemplified by
Fig. 3 Systolic and diastolic flow velocities behavior during a drop
of cerebral perfusion pressure during a plateau wave increase in ICP
observed in a traumatic brain-injured patient (source: Brain Physics
Laboratory TBI Database, University of Cambridge). FVd component
in this case indicates inadequate cerebral perfusion. CPP cerebral
perfusion pressure, FVs systolic flow velocity, FVd diastolic flow
velocity, ICP intracranial pressure, TBI traumatic brain injury
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the fact that in certain situations where changes of ICP
related to vasogenic fluctuations (plateau waves, B waves)
overlaps the changes of ICP related to CSF circulation (for
instance during CSF infusion test), there is a strong cor-
relation in time domain between real and TCD-estimated
ICP (as seen in Fig. 6, obtained from Cardim et al. [44]),
even showing reliable replications of vasogenic waves
patterns.
According to the revision of the presented methods, the
measures of accuracy for each method varied substantially
within and among nICP categories as observed in Tables 1,
2 and 3. For the approaches based on mathematical models,
for instance, the most frequent measures were the ‘Bias’
and ‘SDE’ (standard deviation of the error [bias]), and
MAD (mean absolute difference).
Over measures of accuracy, a standard statistical
assessment would be interesting for works on non-invasive
intracranial pressure methods. For instance, at least for a
clinical point of view, an assessment should contain the
following statistical indicators: (I) correlation between
nICP and measured ICP considering mean values of ICP
and changes of ICP in time domain; (II) Bias and 95 % CI
for prediction of ICP; (III) ROC analyses including the
nICP method prediction ability at a certain threshold
(usually around 20 mmHg for intracranial hypertension),
sensitivity and specificity. Altogether, these parameters
should provide the clinician a comprehensive picture of the
qualities and downsides of a method.
Another aspect that might confuse interpretation and
comparisons is how the nICP averages were obtained, i.e.,
every work present with different average calculation
windows. The number of samples should also be consid-
ered when comparing such results. Moreover, information
about sensitivity and specificity, confidence intervals for
prediction or any of the above mentioned parameters is not
systematically available in the majority of the reviewed
papers. Some of the studies also include a small number of
patients, making a quantitative comparison unfeasible. This
variability illustrates the importance and necessity of
studies applying the same number of samples, calculation
methods and measures of accuracy in order to compare
different nICP methods consistently.
Fig. 4 Representation of the CrCP interaction with ICP and WT in a
situation of intracranial hypertension observed in a traumatic brain-
injured patient (source: Brain Physics Laboratory TBI Database,
University of Cambridge). During the increase of ICP, the CrCP also
increases and WT decreases as an effect of preserved autoregulation.
ABP arterial blood pressure, CrCP critical closing pressure, ICP
intracranial pressure, WT wall tension, TBI traumatic brain injury
Fig. 5 Schematic representation of the black-box model (Schmidt
et al. [20]), for nICP estimation. A known transfer function
(represented by a linear model) between ABP and FV, alongside
modification (TCD) characteristics are used as means to dynamically
define the rules for a transformation of ABP into nICP (unknown
transfer function—a linear model between ABP and ICP). ABP
arterial blood pressure, FV cerebral blood flow velocity, TCD
transcranial Doppler, nICP non-invasive intracranial pressure
Neurocrit Care
123
Fig. 6 Example of vasogenic waves during CSF infusion test
(Cardim et al. [44]). Shadowed areas in (a) and (b) represent ICP
waves of vasogenic origin. It is possible to observe that at least for
trends in time, there were good correspondence between ICP and
nICP methods; nICP_BB non-invasive ICP method based on math-
ematical black-box model [6]; nICP_FVd non-invasive ICP method
based on FVd [10]; nICP_CrCP non-invasive ICP method based on
CrCP [18]; nICP_PI non-invasive ICP method based on PI
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The several degrees of approximation for ICP monitor-
ing (i.e., epidural, subdural, intraparenchymal and
intraventricular) could also contribute to a misleading
interpretation when validating nICP methods against dif-
ferent invasive techniques. This is due to the presence of
multiple intracranial compartments of variable deforma-
bility and ability to transmit pressure. Thus, ICP needs to
be considered as an anisotropic parameter rather than a
global isotropic pressure equally distributed in all
intracranial compartments. Over this concept, each inva-
sive method would then be specific to measuring
compartmental pressures according to where they are
located in the intracranial system. As proofs of this
concept, simultaneous measurement of ICP by intra-
parenchymal and intraventricular probes showed a bias of
-1.2 and a 95 % CI of ±6.8 mmHg (SDE of ±3.4 mmHg)
[45]. In another study, simultaneous measurements of ICP
using intraparenchymal and epidural probes presented a
bias of 4.3 mmHg, with 95 % CI of ±17 mmHg (SDE of
±8.5 mmHg) [46]. Under these circumstances, the char-
acteristics of invasive ICP monitoring should also be
considered in the standard nICP assessment.
Nevertheless, qualitative-wise, TCD-based nICP meth-
ods generally presented a positive degree of agreement and
acceptable correlations with measured ICP (or with CPP
for nCPP-based methods), with exceptions for PI-based
methods. For this category, even though most of the studies
indicated a direct, or at least indirect, correlation between
PI and ICP, there is a divergence whether PI can predict
ICP reliably, with some studies showing rather weak or
even inexistent correlations between these two parameters
[6, 19, 47–51]. Such a controversy might originate from the
different conditions in which PI can increase independently
of increases in ICP.
Considering the 95 % CI for the presented methods,
there is a wide variability for the different method cate-
gories (from ±4.2 to ±59.60 mmHg). The authors’
personal experience on working with TCD-based methods
suggests there is an overall intrinsic confidence interval of
around ±12 mmHg, which still needs to be extensively
validated in different patient populations and clinical
conditions. Provided that the clinically relevant range of
ICP is about 10 or 20 mmHg, TCD-based methods at the
current state of development are not able to predict mean
values of ICP with great confidence. However, the cerebral
circulation dynamics can be observed with such methods as
nICP changes in time domain, and tracked in real-time in
the clinical setting (as observed in Fig. 6, for instance).
This is one of the advantages of Transcranial Doppler
Ultrasonography and may become particularly useful as a
primary assessment tool in centres where ICP measure-
ments are not routinely applied, or in patients in whom ICP
monitoring is unavailable or may not be clearly indicated.
In conclusion, although Transcranial Doppler Ultra-
sonography consists of a technique with various
possibilities for nICP estimation, there is still a necessity of
studies to systematically compare them in different clinical
conditions, in order to determine which approach offers the
best reliability to monitor ICP dynamics non-invasively.
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